Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (1478 total)
-
Creator: NETEC
Subject: Infection Control
Item Type: Guide
Date Last Updated: 2021-07-29
Description: On July 27, the Centers for Disease Control and Prevention (CDC) updated guidance for fully vaccinated people given new evidence on the B.1.617.2 (Delta) variant of COVID-19 currently circulating in the United States. Updated mask guidelines (at the… -
Creator: NETEC
Subject: Emergency Medical Services
Item Type: Guide
Date Last Updated: 2021-07-23
Description: On July 8-9 a U.S. citizen traveled from Nigeria to Dallas, TX, via Atlanta, GA. On July 13 the patient presented to an emergency department for a rash that had been present since July 7. The patient was diagnosed with Mpox and isolated.This blog… -
Creator: The Medical Letter on Drugs and Therapeutics
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2021-07-15
Description: COVID-19 Vaccine Comparison Chart (online only) effectiveness by vaccine and by variant. -
Creator: Chu, Victoria T., Anna R. Yousaf, Karen Chang, Noah G. Schwartz, Clinton J. McDaniel, Scott H. Lee, Christine M. Szablewski, Marie Brown, Cherie L. Drenzek, Emilio Dirlikov, Dale A. Rose, Julie Villanueva, Alicia M. Fry, Aron J. Hall, Hannah L.…
Subject: Infection Control
Item Type: Publication
Date Last Updated: 2021-07-21
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children is often asymptomatic or results in only mild disease. Data on the extent of transmission of SARS-CoV-2 from children and adolescents in the household setting,… -
Creator: NETEC
Subject: Waste Management
Item Type: Guide
Date Last Updated: 2021-07-21
Description: The United States recently had a case of Mpox virus diagnosed in a patient in Dallas County, Texas. Organizations in the U.S. now preparing for the potential need to handle patients under investigation or patients with the Mpox virus must also… -
Creator: Kadri, Sameer S., Junfeng Sun, Alexander Lawandi, Jeffrey R. Strich, Lindsay M. Busch, Michael Keller, Ahmed Babiker, Christina Yek, Seidu Malik, Janell Krack, John P. Dekker, Alicen B. Spaulding, Emily Ricotta, John H. Powers Iii, Chanu Rhee,…
Subject: Emergency Management
Item Type: Publication
Date Last Updated: 2021-07-06
Description: Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival.Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Creator: the Pipeline and Hazardous Materials Safety Administration
Subject: Waste Management
Item Type: Guide
Date Last Updated: 2005-05-19
Description: The requirements adopted for the UN Recommendations establish a two-tiered classification system for Division 6.2 materials—Category A and Category B. A Category A infectious substance poses a higher degree of risk than a Category B infectious… -
Creator: NETEC
Subject: Waste Management
Item Type: Guide
Date Last Updated: 2019-08-29
Description: When treating a patient with Ebola virus disease, hospitals and health care providers must safely handle, transport, and dispose of waste. Dr. Shawn Gibbs, PhD, MBA, CIH executive associate dean and professor with Indiana University School of Public… -
Creator: NETEC
Subject: Infection Control
Item Type: Guide
Date Last Updated: 2021-07-19
Description: NETEC recommends the “Identify, Isolate, and Inform” strategy. In this article, we provide a quick list of transmission precautions, PPE, waste, and other medical countermeasures. -
Creator: Public Health Agency of Canada
Subject: General
Item Type: Hyperlink
Date Last Updated: 2011-02-18
Description: PATHOGEN SAFETY DATA SHEET - INFECTIOUS SUBSTANCES SECTION I - INFECTIOUS AGENTSECTION II – HAZARD IDENTIFICATIONSECTION III - DISSEMINATIONSECTION IV - STABILITY AND VIABILITYSECTION V – FIRST AID / MEDICALSECTION VI - LABORATORY HAZARDSSECTION VII…